- Comparison of the effect of teriparatide and risedronate on bone loss in postmenopausal women with multiple sclerosis treated with low-dose glucocorticoids2015 | First Faculty of Medicine
- Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial2018 | Publication without faculty affiliation
- Gastrointestinal safety of the treatment with risedronatePublication without faculty affiliation
- Gastrointestinal safety of the treatment with risedronate in patients taking NSAIDsPublication without faculty affiliation
- Phase 3 randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer2009 | Publication without faculty affiliation
- Crystallization Products of Risedronate with Carbohydrates and Their Substituted Derivatives2011 | Faculty of Pharmacy in Hradec Králové
- Efficacy of teriparatide compared with risedronate on FRAX(R)-defined major osteoporotic fractures: results of the VERO clinical trial2020 | First Faculty of Medicine
- Risedronate has no adverse effects on mouse haematopoiesis2007 | First Faculty of Medicine
- Serum 25-hydroxy-vitamin D and the risk of fractures in the teriparatide versus risedronate VERO clinical trial2019 | First Faculty of Medicine
- Effect of Teriparatide or Risedronate in Elderly Patients With a Recent Pertrochanteric Hip Fracture: Final Results of a 78-Week Randomized Clinical Trial2017 | First Faculty of Medicine
- Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial2018 | First Faculty of Medicine
- Effects of Teriparatide Compared with Risedronate on Recovery After Pertrochanteric Hip Fracture: Results of a Randomized, Active-Controlled, Double-Blind Clinical Trial at 26 Weeks2016 | First Faculty of Medicine
- Guidelines for diagnostics and therapy of postmemnopausal osteoporosis. Second part2007 | Publication without faculty affiliation
- Guidelines for diagnostics and therapy of postmemnopausal osteoporosis. Second part2007 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Guidelines for diagnostics and therapy of postmemnopausal osteoporosis. Second part2007 | First Faculty of Medicine
- Limited walking ability significantly contributes to a loss of bone mineral density in the proximal femur in premenopausal and postmenopausal women with multiple sclerosis2012 | First Faculty of Medicine
- Marked reduction of bone turnover by alendronate attenuates the acute response of bone resorption marker to endogenous parathyroid hormone2009 | First Faculty of Medicine
- Self-reported compliance with osteoporosis medication - Qualitative aspects and correlates2008 | Faculty of Pharmacy in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Hradec Králové